Detalles de la búsqueda
1.
Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.
Blood
; 132(15): 1604-1613, 2018 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30108064
2.
Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy.
Blood
; 129(1): 38-47, 2017 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27733357
3.
DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(1): 61-70, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26234722
4.
Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen.
BMC Cancer
; 16: 613, 2016 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27501959
5.
Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry.
Ann Hematol
; 95(1): 125-133, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26416513
6.
Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen.
Ann Hematol
; 95(1): 55-61, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467916
7.
Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression.
Ann Hematol
; 95(10): 1645-51, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27365142
8.
Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.
Ann Hematol
; 95(4): 625-35, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26692090
9.
Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
Ann Hematol
; 95(2): 301-10, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26537612
10.
Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry.
J Korean Med Sci
; 31(2): 214-21, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26839475
11.
Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients.
J Korean Med Sci
; 31(7): 1160-3, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27366017
12.
Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study.
J Korean Med Sci
; 31(12): 1914-1921, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27822929
13.
Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma.
BMC Cancer
; 15: 198, 2015 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25879747
14.
Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large B-cell lymphoma.
Acta Haematol
; 133(1): 10-7, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-24969101
15.
Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome.
Acta Haematol
; 134(1): 40-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26066466
16.
Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors.
Haematologica
; 99(7): 1191-6, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24705186
17.
Decreased body mass index is associated with poor prognosis in patients with multiple myeloma.
Ann Hematol
; 93(5): 835-40, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24310866
18.
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
Ann Hematol
; 93(1): 33-42, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23807252
19.
Advanced lytic lesion is a poor mobilization factor in peripheral blood stem cell collection in patients with multiple myeloma.
J Clin Apher
; 29(6): 305-10, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24764270
20.
Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines.
J Korean Med Sci
; 29(2): 164-71, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24550640